For most of my career, I've been working at the boundary of two disciplines: machine learning and biomedicine. But until recently, machine learning has not had the same impact on biomedicine as it's had on so many other challenging domains. The reason for that is twofold: not enough high-quality, relevant data; and not enough bilingual people who understand both domains and are able to identify the important problems and design the right solutions. At insitro, we aim to address both these challenges, and help address an important societal problem: design novel, safe, and effective therapies that help more people, faster, and at a lower cost. We have many exciting and challenging problems, and are building a diverse team of exceptionally talented people. Please join us! Learn more about Daphne Koller's work experience, education, connections & more by visiting their profile on LinkedIn